Mylan-Divalproex 250 mg (Valproic Acid (Divalproex Sodium) TABLET (DELAYED-RELEASE)) 250 MG

MYLAN-DIVALPROEX 250 MG is a delayed-release tablet containing valproic acid (divalproex sodium). This medication is commonly used to manage certain types of seizures and mood disorders. It is manufactured by Mylan Pharmaceuticals ULC in Canada.

Strength

250 MG

Pack Size

100/500

Manufacturer / TM Owner

MYLAN PHARMACEUTICALS ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MYLAN-DIVALPROEX 250 MG is primarily used for the treatment of epilepsy and bipolar disorder. It works by affecting the central nervous system to prevent seizures and stabilize mood. This medication is often prescribed for long-term management of these conditions.

Side Effects

Common effects of MYLAN-DIVALPROEX 250 MG may include drowsiness, dizziness, and nausea. Some users might experience weight changes or tremors. These effects can vary depending on individual tolerance and dosage.

Precautions & Warnings

MYLAN-DIVALPROEX 250 MG should be handled with care, especially by those with liver or pancreatic conditions. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping this medication. Keep out of reach of children.

Avoid Interactions

MYLAN-DIVALPROEX 250 MG may interact with other medications, including those that affect the central nervous system. Alcohol and certain over-the-counter drugs can also interact with this medication. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

MYLAN-DIVALPROEX 250 MG is used to manage epilepsy and bipolar disorder by affecting the central nervous system.

MYLAN-DIVALPROEX 250 MG is taken orally as a delayed-release tablet. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include drowsiness, dizziness, nausea, weight changes, and tremors.

MYLAN-DIVALPROEX 250 MG may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

MYLAN-DIVALPROEX 250 MG is often prescribed for long-term management of epilepsy and bipolar disorder, but regular monitoring by a healthcare provider is recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.